Results 31 to 40 of about 1,036,661 (382)

Overview of drugs approved by the FDA in 2022

open access: yesФармация и фармакология (Пятигорск), 2023
The aim of the work is to conduct a review of medications approved by the FDA in 2022.Materials and methods. In searching for the materials to write this review article, bibliographic databases including PubMed, Google Scholar and e-library.ru were ...
D. V. Kurkin   +14 more
doaj   +1 more source

The FDA “black box” warning on antidepressant suicide risk in young adults: More harm than benefits? [PDF]

open access: yes, 2019
The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed warning on antidepressants regarding the risk of suicidality in young adults still represents a matter of controversy.
Anastasia A.   +12 more
core   +1 more source

FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation

open access: yesNature Immunology, 2020
Cytosolic sensing of pathogens and damage by myeloid and barrier epithelial cells assembles large complexes called inflammasomes, which activate inflammatory caspases to process cytokines (IL-1β) and gasdermin D (GSDMD).
J. Hu   +17 more
semanticscholar   +1 more source

FDA-Approved Trifluoromethyl Group-Containing Drugs: A Review of 20 Years

open access: yesProcesses, 2022
As people around the world regard 2020 as the year of COVID-19, the medical community considers this year to be the second-best year, shared with the year 1996, with respect to the number of drug molecules approved by the US Food and Drug Administration (
Aathira S. Nair   +9 more
semanticscholar   +1 more source

SENTINEL SYSTEM – electronic system for collecting real-world data

open access: yesРеальная клиническая практика: данные и доказательства, 2022
The need to use more and more data to generate evidence in response to new challenges in clinical medicine requires a specific response from the healthcare system. The high pace of development of medicine, the acceleration of the development of new drugs
E. O. Eremenko, M. I. Baranova
doaj   +1 more source

An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy

open access: yesMolecules, 2021
The large number of emerging antibody-drug conjugates (ADCs) for cancer therapy has resulted in a significant market ‘boom’, garnering worldwide attention.
Juliana T W Tong   +3 more
semanticscholar   +1 more source

Frequency and Severity of Neutropenia Associated with Food and Drug Administration Approved and Compounded Formulations of Lomustine in Dogs with Cancer. [PDF]

open access: yes, 2015
BackgroundCompounded lomustine is used commonly in veterinary patients. However, the potential variability in these formulations is unknown and concern exists that compounded formulations of drugs may differ in potency from Food and Drug Administration ...
Burton, JH   +5 more
core   +2 more sources

Free Differential Algebras: Their Use in Field Theory and Dual Formulation [PDF]

open access: yes, 1995
The gauging of free differential algebras (FDA's) produces gauge field theories containing antisymmetric tensors. The FDA's extend the Cartan-Maurer equations of ordinary Lie algebras by incorporating p-form potentials ($p > 1$).
Alberto Perotto   +7 more
core   +2 more sources

Effects of α subunit substitutions on the oxidation of βCys93 and the stability of sickle cell hemoglobin

open access: yesRedox Report, 2020
The β subunit substitutions, F41Y and K82D, in sickle cell hemoglobin (Hb) (βE6 V) provides significant resistance to oxidative stress by shielding βCys93 from the oxidizing ferryl heme.
Wayne Hicks   +3 more
doaj   +1 more source

Valuation implications of pharmaceutical companies' R&D regulatory approval notifications [PDF]

open access: yes, 2013
This paper examines shareholder wealth effects surrounding applications to, and approvals by, the United States Food and Drug Administration (FDA) for firms listed on the New York (NYSE) and London (LSE) stock exchanges.
Hamill, P.A., McIlkenny, P., Opong, K.K.
core   +1 more source

Home - About - Disclaimer - Privacy